Please login or sign up to post and edit reviews.
"Accelerating and Growing the Drug Development Pipeline…"
Podcast |
Connecting ALS
Publisher |
ALS Association
Media Type |
audio
Categories Via RSS |
Health & Fitness
Society & Culture
Publication Date |
Feb 24, 2022
Episode Duration |
00:16:03

This week Jeremy checks in with Dr. Neil Thakur, The ALS Association’s Chief Mission Officer, for an update on implementing the ACT for ALS and digs into the latest developments on reviews of AMX0035 by the FDA and ICER.

Learn more about ICER’s review of AMX0035 at https://www.als.org/icer

To hear more about the path to bringing AMX0035 to people with ALS, check out https://www.connectingals.org/episodes/fight-for-amx0035-approval-moves-forward-with-amylyx-nda-announcement

Sign up to become an advocate and join the fight to full fund ACT for ALS at https://als.quorum.us/register/

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

Welcome to Connecting ALS. This week we turn to Dr. Neil Thakur for an update on implementing the ACT for ALS and we dig into the latest developments on reviews of AMX0035 by the FDA and ICER.

This week Jeremy checks in with Dr. Neil Thakur, The ALS Association’s Chief Mission Officer, for an update on implementing the ACT for ALS and digs into the latest developments on reviews of AMX0035 by the FDA and ICER.

Learn more about ICER’s review of AMX0035 at https://www.als.org/icer

To hear more about the path to bringing AMX0035 to people with ALS, check out https://www.connectingals.org/episodes/fight-for-amx0035-approval-moves-forward-with-amylyx-nda-announcement

Sign up to become an advocate and join the fight to full fund ACT for ALS at https://als.quorum.us/register/

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review